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Human isolates of Aeromonas possess Shiga
toxin genes (stx1 and stx2) highly similar
to the most virulent gene variants of
Escherichia coli
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Abstract
Strains producing Shiga toxins, encoded by stx1 and stx2 genes,
can cause diarrhoea, haemorrhagic colitis and haemolytic uremic
syndrome. PCR screening of 80 clinical Aeromonas strains
showed that 19 were stx1-positive and only one was positive for
both stx1 and stx2. PCR bands were very faint for some strains
and negative results were obtained after subculturing. The
CMI Research Notes 1563
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 1555–1567
obtained sequences of Aeromonas stx1 and stx2 genes were
highly similar to those of the most virulent stx gene variants of
Shiga toxin-producing Escherichia coli. These results may lead to
a better understanding of the potential pathogenicity and viru-
lence mechanisms of Aeromonas.
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Shiga toxins (Stx1 and Stx2) are important virulence factors
in the pathogenesis of gastroenteritis, hemorrhagic colitis
and haemolytic-uremic syndrome (HUS) [1–3]. They are usu-
ally encoded in the genome of bacteriophages (highly mobile
elements) that play a role in Stx expression and horizontal
gene transfer, leading to the emergence of new stx-variants
or stx-producing pathogens [4]. Several variants of stx1 and
stx2 genes have been recognized [2,3], with stx2 (the proto-
type) and stx2c being considered the most important because
they are more frequently associated with HUS than stx1 and
stx2dactivatable [2,3,5]. The stx genes show instability in vivo
and in vitro as a result of the mobility of stx-phages [4,6],
leading to the loss of stx genes after subculturing and/or
infection [1,4,6–8].
Despite Shiga toxins being typical of Shigella dysenteriae
and Shiga toxin-producing E. coli (STEC), they have also been
described in species of other genera, including Aeromonas [7–
12]. In Aeromonas, the presence of stx1 gene has only been
detected in ﬁve strains [11,12] but never sequenced, and it is
not known whether they have the stx2. Despite that, several
cases of HUS associated with Aeromonas have been reported
[13]. The present study investigates the stx genes (stx1 and
stx2) in 80 human Aeromonas strains by PCR and sequencing.
All investigated strains (33 from extra-intestinal infections
and 47 from diarrhoea) were genetically identiﬁed [14]. The
strain of Aeromonas veronii bv. sobria associated with a case
of HUS [13] was also tested. DNA was extracted from single
colonies grown on sheep blood agar (24 h at 30C) using
InstaGene Matrix (Bio-Rad, Hercules, CA, USA). Separate
PCRs for the detection of stx1 (350 bp) and stx2 (406 bp)
with primers EVT-1&2 and EVS-1&2, respectively (TaKaRa
Biomedicals, Tokyo, Japan) with positive and negative
controls were employed [11]. PCR products were puriﬁed
using GFX PCR DNA and the Gel Band Puriﬁcation Kit
(Amersham Biotech, Little Chalfont, UK) and sequenced on
both strands using the TaKaRa primers (3.2 pmol/lL) in an
ABI PRISM 310 genetic analyzer (Applied Biosystems, Foster
City, CA, USA). Using CLUSTAL W, the stx1 and stx2 obtained
sequences were independently aligned with those available in
the GenBank to establish their similarity. Their genetic rela-
tionships were graphically represented as phylogenetic trees
using the neighbour-joining method, as described previously
[14].
Nineteen of the 80 Aeromonas strains showed a band of
the expected size (350 bp) for the stx1 and one of them also
the band (406 bp) of stx2. However, in 15 of the 19 strains,
the stx1 bands were faint as was also the stx2 band (Fig. 1a,
b). The strain of A. veronii bv. sobria associated with a case
of HUS [13] did not show even faint bands. To verify the
results, the same DNA of the 19 stx1-positive strains was
evaluated again under identical conditions and only four
(875c, 883c, 885c and 887c) strains were positive for the
stx1. Negative results corresponded with strains showing
faint bands in the ﬁrst analysis. The 19 Aeromonas strains
were grown again from the glycerol stock and stx1 was
ampliﬁed from a new DNA extraction. The results obtained
reproduced the initial ﬁnding, with the appearance of the
same 15 strains with faint stx1 bands and four with intense
bands. The PCR for the stx2-positive strain (819c) was per-
formed ﬁve times from four different DNA extractions from
the same frozen stock and the expected band (406 bp) was
only observed on two of ﬁve (40%) occasions as a faint band
(Fig. 1c). These faint bands can be explained by the number
of copies of stx genes in the template DNA [7] and their loss
after subculture or infection agrees with previous ﬁndings
[1,4,6–8], and may also explain the lack of ampliﬁcation in
the HUS isolate of A. veronii bv. sobria.
Snowden et al. [12] detected stx1 in only one environmen-
tal strain of A. veronii using other primers [15]. We evaluated
the same primers, although the expected 121 bp band of
stx1 could not be ampliﬁed in any of the 19 stx1-positive
strains.
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We found more stx1-positive Aeromonas strains (23.75% 19/
80) than in previous studies (10.25% 4/39) [11] and (9.1% 1/
11) [12]. They were predominantly encountered in Aeromonas
caviae (42.1% 8/19), Aeromonas hydrophila (31.6% 6/19) and
A. veronii (10.5% 2/19), which are species commonly associated
with gastroenteritis and even with a dysentery-like syndrome
and HUS [13,16,17]. The only stx1-stx2-positive strain (819c)
belonged to A. caviae and was isolated from a urine sample.
Sequences (350 bp) of stx1 of the four Aeromonas strains
with intense bands were identical and showed 99.71% simi-
larity (one different nucleotide) to the corresponding region
of this gene of E. coli O157:H7, whereas a 99.51% similarity
(two different nucleotides) was shown for the stx2 sequence
of strain 819c (406 bp). The analysis showed that our stx1
sequences clustered with those from S. dysenteriae, Shigella
sonnei, E. coli O157:H7 and other STEC human isolates
(Fig. 2a), whereas A. caviae stx2 sequence clustered (Fig. 2b)
with those of the most virulent human variants (stx2 proto-
type and stx2c) that are commonly associated with HUS
[2,3]. This may suggest an equally potential role of both
genes in Aeromonas and horizontal gene transfer [4] among
those microorganisms, which is not surprising because they
inhabit the same environments.
To determine whether the observed instability of stx1 was
a result of its extra-chromosomal DNA location, this DNA,
from strains 535c representative of strains with a faint band,
and 887c with a strong band, was extracted using Ultraclean
6 minute mini plasmid prep kit (Mo Bio, Carlsbad, CA, USA).
A single band (approximately 3.2 kbp) of extra-chromosomal
DNA was obtained from both strains. This DNA was used as
a template for stx1-PCR ampliﬁcation [11] and a band of the
expected size (350 bp) for stx1 as intense as the positive
control (E. coli O157:H7) was only observed from strain
535c (Fig. 1c). This indicated that, at least in strain 535c and
in the four strains reported by Haque et al. [11], the stx1 is
not chromosomally encoded. These results corroborate
the mobility of the stx-phages that can be lost by subculturing
[4].
To determine the production of Stx1 and Stx2 toxins by
the PCR positive strains, a rapid immunochromatographic
test (Duopath Verotoxin test; Merck, Darmstadt, Germany)
was used. Only strains 885c (which showed an intense stx1
band by PCR) and 535c (with a faint PCR band) showed a
weak Stx1 signal, although none of the strains showed a Stx2
positive reaction. In conclusion, 10.53% (2/19) of the
Aeromonas strains that possessed stx1 produced the Stx1
toxin. Similar values (using the same test) have been
reported from STEC strains (6.7% produced Stx1 and 6–7%
produced Stx2) from human wastewater [18]. However,
the results obtained in the present study could be inﬂuenced
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FIG. 1. Examples of PCR ampliﬁcations
demonstrating the presence of stx genes
in Aeromonas strains. 25 lL of PCR
product electrophoresed in 1% agarose
gel. (a) stx1 strong and faint bands. Lane
1, 875c; lane 2, 883c; lane 3, 885c; lane
4, 887c; lane 5, 194c; lane 6, 361c; lane
7, 191c; lane 8, 24c. (b) stx2 faint bands.
Lane 1, 875c; lane 2, 819c; lane 3, 819c
(duplicate PCR product). (c) stx1 ampli-
ﬁed from plasmid DNA. Lane 1, 535c.
Lane C+, positive control Escherichia coli
O157:H (CECT 4076). Lane C–, nega-
tive control (Milli-Q water as template
DNA; Millipore, Billerica, MA, USA).
Lane M, Ladder 100 bp. Aeromonas cavi-
ae strains: 535c, 819c, 875c, 883c and
885c; Aeromonas hydrophila strains: 24c,
191c, 194c and 887c; Aeromonas salmoni-
cida strain 361c.
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To our knowledge, this is the ﬁrst report to provide
Aeromonas stx1 and stx2 sequences that establish their
high similarity with those of STEC. This is of particular
importance because these genes have been poorly studied
in Aeromonas and they may have a role in inducing
diarrhoea and HUS.
The sequences of the stx1 and stx2 genes have been
deposited in GenBank under accession numbers GU130282-
GU130285 and GU130286, respectively.
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